Cargando…
Galectin-3 and fibulin-1 in systolic heart failure - relation to glucose metabolism and left ventricular contractile reserve
BACKGROUND: Heart failure (HF) patients with diabetes (DM) have an adverse prognosis and reduced functional capacity, which could be associated with cardiac fibrosis, increased chamber stiffness and reduced left ventricular (LV) contractile reserve. Galectin-3 (Gal-3) and fibulin-1 are circulating b...
Autores principales: | Holmager, Pernille, Egstrup, Michael, Gustafsson, Ida, Schou, Morten, Dahl, Jordi S., Rasmussen, Lars Melholt, Møller, Jacob E., Tuxen, Christian, Faber, Jens, Kistorp, Caroline |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5223321/ https://www.ncbi.nlm.nih.gov/pubmed/28068900 http://dx.doi.org/10.1186/s12872-016-0437-6 |
Ejemplares similares
-
Plasma Fibulin-1 Is Linked to Restrictive Filling of the Left Ventricle and to Mortality in Patients With Aortic Valve Stenosis
por: Dahl, Jordi S., et al.
Publicado: (2012) -
End-systolic wall stress in aortic stenosis: comparing symptomatic and asymptomatic patients
por: Carter-Storch, Rasmus, et al.
Publicado: (2019) -
Galectin 3: association to neurohumoral activity, echocardiographic parameters and renal function in outpatients with heart failure
por: Stoltze Gaborit, Freja, et al.
Publicado: (2016) -
Empagliflozin in heart failure patients with reduced ejection fraction: a randomized clinical trial (Empire HF)
por: Jensen, Jesper, et al.
Publicado: (2019) -
Effects of Empagliflozin on Myocardial Flow Reserve in Patients With Type 2 Diabetes Mellitus: The SIMPLE Trial
por: Jürgens, Mikkel, et al.
Publicado: (2021)